Innovating targeting

Philogen is a Swiss-Italian biotechnology company, founded in 1996 and listed on the Italian Stock Exchange, with a mission to innovate the treatment of cancer and other serious conditions

Innovating targeting

Philogen is a Swiss-Italian biotechnology company, founded in 1996 and listed on the Italian Stock Exchange, with a mission to innovate the treatment of cancer and other serious conditions

 

Philogen to attend the EFMC ISMC 2024 on September 4, 2024 in Rome

Dr. Samuele Cazzamalli is giving a presentation entitled "DNA-Encoded Chemical Libraries for the Discovery of Highly Potent Tumor-Targeting Ligands and for the...

Philogen to attend PEGS2024 on September 6, 2024 in Barcelona

Dr. Samuele Cazzamalli is giving a presentation entitled "From DNA-Encoded Chemistry to anti-cancer Radio Ligand Therapeutics and Small Molecule-Drug Conjugates"....

Philogen is pleased to invite you to a new webinar on July 10, 2024, at 14:00 GMT | 15:00 CET.

Management will provide an update on the industrial programs, including on the topline results from the Nidlegy™ Phase III trial presented at ASCO 2024. Please contact...

Submission of NidlegyTM Marketing Authorization Application Validated by EMA

For more details

Nidlegy™ Marketing Authorization Application Submitted to EMA

more details

Richiesta di autorizzazione all’immissione in commercio per il prodotto Nidlegy™ sottomessa all’EMA

more details

Risultati dello studio clinico di Fase III PIVOTAL di Nidlegy nel melanoma da presentare all’ASCO 2024

More details

Results of the Phase III PIVOTAL trial of Nidlegy in melanoma to be presented at ASCO 2024

More details

Deposito del Verbale dell’Assemblea degli Azionisti

more details

Philogen to attend the Goldman Sachs 45th Annual Global Healthcare Conference in Miami on June 12, 2024.

The conference provides an opportunity for investors to learn about Philogen's progress and to meet CEO/CSO Prof. Dario Neri through a series of one-on-one meetings....

OUR SCIENCES

Learn about our strategy

PIPELINE

Learn more about our pipeline

WORK WITH US

Look at open positions